Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-31

Clinical Trial Update: Efficacy and Safety of GTR in Comparison to Copaxone® [Phase 3]

View source ↗

Summary

A phase 3 trial comparing GTR to Copaxone in multiple sclerosis reports efficacy and safety results; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COPAXONE (GLATIRAMER ACETATE)
  • GTR

Snippet

Sponsor: Synthon BV | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2016-10-31